28 results on '"PIRO, EUGENIO"'
Search Results
2. Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs
3. Amyloid in bone marrow smears of patients affected by multiple myeloma
4. Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study
5. A Systematic Review on the Use of Bortezomib in Multiple Myeloma Patients with Renal Impairment: What Is the Published Evidence?
6. A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling
7. Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics
8. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA
9. High-Dose Therapy and Autologous Peripheral Blood Stem Cells Transplantation Followed by a Very Low Reduced Intensity Regimen With Fludarabine + Cyclophosphamide and Allograft Improve Complete Remission Rate in De Novo Multiple Myeloma Patients
10. A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients
11. Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib
12. Sustained Erythroid Response in a Patient with Myelofibrosis Receiving Concomitant Treatment with Ruxolitinib and Deferasirox
13. Bacillus cereus Catheter-Related Infection in Acute Lymphoblastic Leukemia (ALL) Patient: A Case Report and Review of Literature
14. A Simple Score, Based on Geriatric Assessment, Predicts Survival in Elderly Newly Diagnosed Chronic Lymphocytic Leukemia Patients
15. Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting
16. A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients.
17. Progressive Peripheral Arterial Occlusive Disease and Other Vascular Events During Nilotinib Therapy in Chronic Myeloid Leukemia
18. Long-term results in multiple myeloma treated with high-dose melphalan and autologous peripheral stem cell transplantation and achieving complete remission.
19. Reversal of Leukostasis-Related Pulmonary Distress Syndrome After Leukapheresis and Low-Dose Chemotherapy in Acute Myeloid Leukemia
20. Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma
21. SCID-Synth-Hu: a Novel Multiple Myeloma Model for In Vivo Expansion of Primary Cells
22. A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients
23. Sequential Therapy with IMID's in Relapsed-Refractory Multiple Myeloma Patients.
24. MPT Vs ThaDD in Very Elderly Patients with Multiple Myeloma: a Case-Match Study.
25. Amyloid in bone marrow smears of patients affected by multiple myeloma
26. Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study
27. SCID-Synth-Hu: a Novel Multiple Myeloma Model for In VivoExpansion of Primary Cells
28. MPT VsThaDD in Very Elderly Patients with Multiple Myeloma: a Case-Match Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.